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An enzyme-linked immunosorbent assay was used to 
detect class-specific antibodies to wheat protein anti-
gens. Antibodies which we detected by this technique 
reacted indistinguishably with antigens prepared from 
crude gluten, crude gliadin, alpha-gliadin, Frazer frac-
tion ill, and subfraction Band B3 of Frazer fraction ill. 
No sera reacted with a human serum albumin control 
antigen. The prevalence of IgG antibodies to wheat pro-
tein antigens was significantly greater in patients with 
gluten sensitive enteropathy, 12 of 17, (p = .00011) and 
in patients with dermatitis herpetiformis, 5 of 14, (p = 
.046) than in normal control sUbjects. Strongly positive 
reactions for IgG antibodies were present only in pa-
tients with gluten sensitive enteropathy or dermatitis 
herpetiformis. IgA antibodies to wheat protein antigens 
were found only in gluten-sensitive enteropathy pa-
tients. We have found this to be a sensitive, precise 
technique for measurement of antibodies to wheat pro-
tein antigens and feel that it will prove useful in evalu-
ation of the role of immune complexes involving wheat 
protein antigens and their antibodies in the pathogenesis 
of dermatitis herpetiformis. 
Gluten, gliadin and related wheat proteins have been thought 
to have adverse effects upon patients with dermatitis herpeti-
formis (DH), as well as those with coeliac disease, or gluten-
sensitive enteropathy (GSE) [1-6]. Since Marks, Shuster and 
Watson [7] fIrst noted the association between DH and GSE, 
jejeunal mucosal lesions identical to those of GSE have been 
discovered in DH [7-11]. Although the role of wheat proteins 
in producing the cutaneous signs and symptoms of DH is 
unknown, several investigators have implicated wheat proteins 
as toxic factors in DH. A gluten-free diet will reduce medication 
requirements of DH patients and in some cases, maintain a 
remission [12,13]. In patients with DH, a gluten-free diet will 
return jejeunal mucosa to a normal structural appearance, and, 
according to one report, may reduce IgA deposits in the skin 
[14]. Many investigators think that circulating antigen-antibody 
complexes are central to the pathogenesis of DH [1,4]' Investi-
gation of the role of wheat protein in generation of such com-
plexes has been limited by the lack of a sensitive, simple assay 
for antibodies to wheat protein antigens. We report a new 
method to detect antibodies to wheat proteins using an enzyme-
linked immunosorbent assay (ELISA). 
METHODS 
Antigen Sources 
Gluten and gLiadin were obtained from Nutritional Biochemicals 
Division, ICN Pharmaceuticals Inc., Lifesciences Group, Cleveland, 
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Ohio. The antigens prepared from these products were called crude 
gluten and crude gliadin, respectively. . 
Alpha-gliadin was prepared from unmilled Baca hard winter Wheat 
by a method modified from that of Kasarda, Nimmo, and Bernardin 
[15]. The wheat was ground into flour and 200 gm of flour were 
suspended in 500 rnl of 70% ethanol for 3 hr at room temperature. The 
suspension was then centrifuged at 5000 xg for 15 min, and the 
supernatant was lyophilized. To the lyophilized solid, 100 rnl of 0.01 M 
acetic acid were added, and the suspension was fIltered through a 
Whatman #4 fIlter. Sufficient ammonium acetate was added to the 
fIltrate to yield 0.06 ionic strength, and the pH was adj usted to 5.1. The 
solution was divided among 12 ultracentrifuge tubes and rifrigerated at 
4°C overnight. The solution was then ultracentrifuged at 133,000 Xg 
for 3 hr, and the pellets were dissolved in 1 rnl of distilled water. 
Fraction III of a gluten digestion was prepared as described by Frazer 
et aI [16]. To 100 g of gluten (Sigma Chemicals) in 1000 rnl of 0.1 N HCI 
(pH 1.8), 0.5 gm of pepsin were added, and the mixture was incubated 
for 4 hr at 37°C. The pH of the solution was adjusted to 7.8 with 80 rnl 
of 1 N NaOH, and 0.5 gm of trypsin were added for a 4 hr incubation at 
37°C. The pH was lowered to 4.5 with 50 rnl of 1 N HCI, and the 
solu tion allowed to cool to room temperature. The solution was centri-
fuged at 3000 xg for 20 min, and the supernatant of this pepsin-trypsin 
digest (Frazer fraction III) was lyophilized. 
Frazer fraction III was further separated as described by Dissanayake 
et al [17] and Sikora et al [18], by resuspension of the lyophilized 
material in 1000 rnl of sterile distilled water followed by fIltration 
through a UM 10 membrane of Amicon gas sterilized fIltering set for 70 
hr. The residue was resuspended in 1000 rnl of sterile distilled water. 
This material was fIltered through a XM 100a membrane on the 
Amicon fIltration set over 48 hr, and the fIltrate was packed in ice. This 
fIltrate containing subfraction B was lyophilized. 
Two hundred milligrams of lyophilized subfraction B were redis-
solved in 2 rnl of phosphate buffered saline (PBS) and placed over a 2.5 
by 30 cm column of Sephadex G50. Phosphate buffered saline, pH 7.4, 
was used as the elu ting buffer. Fractions of 4 rnl were collected, and 
optical density was determined at 280 nm on a Beckman DU spectro-
photometer. B3 was the first protein peak; B2 the second, and B, the 
third (Fig 1). The protein concentrations in peaks B, and B2 were 
insufficient, and these peaks were not used as antigens. 
Human albumin obtained from Pentex Division of Miles Laborato-
ries, Elkhart, Indiana, was used as a non-wheat protein control antigen. 
A 10 mg sample each of the 7 protein antigens, crude gluten, crude 
gliadin: alpha gliadin, fraction III of gluten, subfraction B, subfraction 
Ba, and human serum albumin, was dissolved in 10 rnl of 0.1 M sodium 
carbonate buffer, pH 9.6. Any undissolved solid was removed by cen-
trifugation. The protein concentration of the antigen solution was 
determined by the Bio-rad protein assay [19]. 
Wash Solutions 
Normal saline containing 0.05% Tween-20 (Sargent-Welch, Skokie, 
ILlinois) was used as a wash solution. 
Peroxidase-Conjugated Antibodies 
Peroxidase-conjugated immunoglobulin fractions of rabbit antisera 
specific for the heavy chains of human IgG, IgA, and IgM were obtained 
from Dako Laboratories, Copenhagen, Denmark. Working dilutions of 
these preparations recommended by the manufacturer were 1:8 to 1:32. 
The conjugated antibody preparations were stored in the dark at 4°C. 
Color Reagent 
Eighty milligrams of 5-aminosalicylic acid (Pfaltz-Bauer, Stamford, 
Connecticut) were dissolved in 100 rnl of distilled water at 70°C. Twelve 
rnl of this solution were filtered, and the pH was adjusted to 6.0 with 1 
N NaOH. A 0.05% hydrogen peroxide solution was prepared by addition 
of 0.1 rnl of a 3% hydrogen peroxide solution (Parke-Davis, Detroit, 
Michigan) to 5.9 rnl of distilled water. Nine rnl of the 5-aminosalicylic 
ac id solution were added to 1 rnl of the 0.05% hydrogen peroxide 
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solution, and this preparation was allowed to stand for 1 hr prior to 
use. A fresh color reagent was prepared for each day's experiment. 
ELISA Technique 
The ELISA used in this study was modified from that described by 
Bullock and Walls [20] and is described in Table I and Fig 2. The 
optimal concentrations of antigens and optimal dilutions of sera and 
conjugates were determined by checkerboard titrations. Sera from 2 
patients known to be sensitive to wheat, one with DR and one with 
GSE, and 2 normal controls were used for these titrations. Because the 
color produced continued to darken, even if 1 drop of 3 N NaOR was 
added, and because of the technical difficu lties of extracting small 
volumes from the wells of a micro titer plate for reading on the spectro-
photometer, in most experiments we chose to assess the reddish-brown 
color produced visually on a 0-4+ scale. 
In checkerboard titration experiments sera were tested at 1: 100, 1: 
200,1:500, and 1:1000 for IgG antibodies, at 1:20, 1:50, and 1:100 for IgA 
antibodies, and at 1:20 and 1:50 for IgM antibodies. The conjugated 
anti-human IgG preparation was tested at 1:30, 1:50, and 1:100; the 
anti-human IgA preparation, at 1:8, 1:10, and 1:16, and the anti-human 
IgM preparation at 1:8, 1:32, and 1:50. The anti-human IgA and anti-
human IgM conjugates were also tested in experiments in which human 
IgA and IgM were fIXed in the wells. Antigens were tested at 10, 20, 50, 
100 and 200 Ilg/ ml. In checkerboard titrations we also prepared wells in 
which no antigen was fIXed, wells in which no serum was added, and 
wells in which no conjugate was added. 
Determination of Precision of Assay 
Twenty-seven serum specimens, 12 of which were positive visually 
for IgG antibodies to crude gluten, were tested again in duplicate, and 
the color intensity was measured in microcells on a Beckman spectro-
photometer at 450 nm 1 hr after the color reagent was added. 
Col umn Chromatography 
of Gluten Fraction mB 
over Sephadex G -SO 
>- 0 .5 
Vi 
Z Bib LU 
a 
-' 
<: 
~ 
.... 
C1.. 
0 
0 
50 75 
FRACTION NUMBER 
FIG 1. Fractionation of gluten subfraction III B by column chro-
matography over Sephadex G-50. Fractions of 4 ml were collected, and 
protein peaks were identified by optical density measurements at 280 
nm. 
TABLE 1. Details of ELISA for antibodies to wheat protein antigens 
L 100 IJ.l of an antigen preparation in 0.1 M carbonate buffer, pH 9.6, 
are added to each well of a Cooke polystyrene microtiter plate, and 
the plate is incubated at 4°C for 72 hr. .. 
2. Each well is gently aspirated and then washed 3 times with ap-
proximately 300 IJ.l of normal saline with 0.05% Tween-20. Aft~r 
each wash, plates are inverted and the wells are allowed to dram 
until no further liquid is obtained. 
3 . Sera to be tested are diluted with PBS containing 0.05% Tween-20. 
To each well 100 III of a serum dilution are added. 
4. Microtiter plates containing serum dilutions are incubated at 37°C 
for 1 hr. 
5 . Wells are emptied and washed 3 times as in Step 2. 
6 . Rabbit anti-human IgG, IgA, or IgM (heavy chain specific) conju· 
gated with peroxidase, is diluted with PBS containing 0.05% Tween-
20, and 100 III of the dilution are added to each well. . 
7. Microtiter plates containing conjugate dilu tions are mcubated at 
37°C for 30 min. 
8 . Wells are emptied and then washed 3 times as in Step 2. 
9 . 200 iLl of the color reagent are added to each well. . 
10. After a 1 hr incubation at room temperature, the color m each well 
is read visually or measured in a spectrophotometer at 450 nm. 
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FIG 2. Schematic diagram of enzyme-linked immunosorbent assay 
(ELISA) used to detect antibodies to wheat protein antigens. 
Sources of Sera 
Sera were obtained from 14 patients with DR, 17 patients with GSE, 
11 patients with other gastrointestinal diseases, 21 patients with ery-
thema multiforme (EM), and 17 normal control subjects. Patients from 
each of the 5 groups were largely young adults in the third and fourth 
decades. Sera from GSE patients and from patients with other gastroin-
testinal diseases were provided as coded specimens by the Division of 
Gastroenterology, University of Colorado Medical Center. 
The diagnosis of DR in the 14 patients was made by the clinical 
features and was confirmed by positive skin immunofluorescence for 
granular IgA deposits in 12. Skin immunofluorescence was negative in 
one patient and was not done in one. All DR patients w~re under 
therapy with either sulfapyridine or dapsone. Most GSE patients were 
on gluten-free diets. The other gastrointestinal diseases included ulcer-
ative colitis, giardiasis, and chronic diarrhea with IgA defiCiency. BlIs-
tering skin lesions were present in 19 of the 21 EM patients. Sera were 
collected from the EM patients during the acute phase of the illness 
while they were under no therapy. . 
The number of positive sera from each of the groups was determmed 
for each class of antibody. The prevalence of positive sera for the 4 
groups of patients was compared with that of the normal control 
subjects by the Fisher's exact test. 
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RESULTS 
The highest dilutions of the conjugates that would reliably 
produce color were 1:50 for anti-human IgG, l :lD for anti-
human IgA, and 1:50 for anti-human IgM. These dilutions, 
rather than lower ones, were chosen so that the expensive 
conjugates would be conserved. 
Serum dilutions which allowed wheat sensitive patients to be 
distinguished from normal controls were 1:200 for IgG deter-
minations and 1:100 for IgA determinations. At lower serum 
dilutions, some nonspecific sticking of immunoglobulin oc-
curred with normal control sera. Nonspecific sticking of IgM 
occurred at serum dilutions less than 1:20. We therefore tested 
sera for IgM antibodies to wheat protein antigens at 1:20 
dilutions. At these serum dilutions the color produced with 
control sera was equivalent visually to that in wells in which no 
serum had been added. 
Sera positive for IgG antibodies to wheat protein reacted 
indi~tinguishably with the six wheat protein antigens. No serum 
specunen reacted when human serum albumin was used as an 
antigen. The color produced with the control antigen was 
visually indistinguishable from that produced when no antigen 
was fixed to the well. Color produced at antigen concentrations 
of 10, 20, and 50 I'g/mJ was only slightly less than that produced 
by 100 and 200 I.lg/mJ. We chose to use the crude gluten antigen 
at 100 I'g/ mJ (10 I.lg protein per well) for further experiments. 
When serum samples were tested in duplicate for IgG anti-
bodies to the crude gluten antigen, the color measured in 
duplicate wells agreed closely. The mean deviation of duplicate 
samples from the mean of the corresponding 2 observations was 
O.OlD optical density units. The deviations represented an av-
erage percentage of their corresponding mean values of 8.4%. 
The results of sera tested at 1:200 for IgG antibodies to the 
crude gluten antigen are shown in Fig 3. Sera which were 
strongly positive at 1:200 (3+ or 4+) were also positive at 1: 
1000. All positive DB sera were from patients with positive 
granular IgA immunofluorescence. 
Only GSE sera demonstrated IgA antibodies to the crude 
gluten antigen when tested at 1:100 (Fig 4). All sera positive for 
IgA antibodies were also positive for IgG antibodies. The 
amounts of IgG binding and IgA binding did not closely corre-
spond; the specimen most positive for IgG antibodies, serum 
from a DB patient, had no demonstrable IgA antibodies. 
No sera with IgM antibodies to the crude gluten antigen were 
found even when sera were tested at 1:20 (Fig 5). 
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FIG 3. Results of ELISA for IgG antibodies to a crude gluten antigen 
in the 5 groups of sera tested. Color intensity rated on a 0 to 4+ scale. 
A +/- color reaction is considered positive. 
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FIG 4. Results of ELISA for IgA antibodies to a crude gluten antigen 
in the 5 groups of sera studied. Color intensity rated on a 0 to 4+ scale. 
A +/- color reaction is considered positive. 
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FIG .5. Results of ELISA for IgM antibodies to a crude gluten 
antigen in 4 of the groups of sera tested. No positive reactions were 
noted. 
A comparison of the prevalence of antibodies of each class to 
the crude gluten antigen is presented in Table II. Compared to 
normal control subjects, IgG antibodies were significantly more 
prevalent in the sera of GSE patients (p "" .00011) and DH 
patients (p "" .046). In the GSE patients the prevalence of IgA 
antibodies was also significantly higher than controls. 
DISCUSSION 
Wheat flour contains 70-75% starch, 1- 2% lipids, 14% water, 
and 7-15% protein [21]. The majority of the proteins are storage 
proteins of the endosperm which act as a nitrogen supply for 
the developing embryo. All species of wheat make similar 
storage proteins. Wheat proteins are separated into 4 classes 
based on their solubility in certain solvents. Globulins are 
soluble in salt solutions; albumins, in water; gliadins, in aqueous 
alcohol; and glutenins, in dilute acid or dilute alkali. The gliadin 
and glutenin components are bound together in a viscoelastic 
macromolecular complex known as gluten [21,22]. Gliadins and 
glutenins may contain common areas of primary and secondary 
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TABLE II. Prevalence of antibodies to wheat protein 
Dermatitis herpeti· 
[ormis 
Gluten sensitive enter-
opathy 
Other bowel disease 
Erythema multiforme 
Normal control sub· 
jects 
IgG 
5/ 14 (36%) 
(p = .046)" 
12/ 17 (71%) 
(p = .00011)" 
1/11 (9%) 
2/21 (10%) 
1/17 (6%) 
IgA 
0/12 (0%) 
5/ 16 (31%) 
(p = .022)" 
0/ 11 (0%) 
0/ 21 (0%) 
0/ 16 (0%) 
U P calculated by comparison with normal controls by exact test. 
IgM 
0/ 12 (0%) 
0/ 13 (0%) 
0/ 7 (0%) 
Not done 
0/16 (0%) 
structures [21). Cross-reactions of rabbit anti-gliadin antibodies 
with glutenin suggest that different classes of wheat proteins 
may share antigenic detenninants [23). Glutamine and proline 
are major amino acid constituents of the gliadins [21). 
Although the carbohydrate fraction of flour was originally 
thought to be the component of flour which produced diarrhea 
in patients with coeliac disease, Dicke, Weijers, and Kamer in 
1953 [24] demonstrated that the component responsible was in 
the protein fraction. Since that time crude gluten [25], crude 
gliadins [25], alpha-gliadin [26], Frazer fraction III [16,17,27] 
and subfractions B, C, B2 and B3 of Frazer fraction III [17,18,27] 
have produced exacerbations of celiac disease. 
As an explanation of how the pathogenesis of DH might be 
related to a gluten sensitive enteropathy, circulating immune 
complexes involving wheat protein antigens have been sug-
gested [1,4]. Detection of circulating immune complexes con-
taining wheat proteins and antibodies to wheat proteins would 
support such a hypothesis. A number of techniques have been 
used in the past for detection of antibodies to wheat protein: 
immunodiffusion [28], passive hemagglutination [29,30], and 
immunofluorescence [31,32]' In most studies complement fixa-
tion studies have been negative [29]. Serum antibodies to wheat 
protein antigens have been found in the majority of patients 
~ith active GSE on a nonnal diet: in 15 of 17 patients by passive 
hemagglutination [30] and in 25 of 25 by immunofluorescence 
~ith antigen-tagged red cell targets [32]. In the immunoflu-
orescent study of Stern, Fischer, and Graltner [32], antibodies 
to wheat proteins in GSE patients are largely of the IgG class, 
although IgM antibodies were also found frequently. Only 20% 
of the patients had IgA antibodies to wheat protein. The 
prevalence of antibodies to wheat proteins and their titers 
decrease when patients are treated with gluten-free diets [31). 
In comparison with GSE patients, wheat protein antibodies 
have been found less frequently in DH patients [31,33,34)' 
Recently, Menzel, Penh amberger, and Holuber detected anti-
bodies in the sera of 5 of 21 DH patients by radioimmunoassay 
[35). 
An ELISA technique has been used by others for detection 
of antibodies to wheat protein, but details of the technique have 
not been given [36). In our laboratory we have found this 
method to be sensitive enough to detect antibodies at high 
serum dilutions. Strong reactions for IgG antibodies were rela-
tively specific for GSE and DH patients. This technique is 
useful because many sera may be tested in a brief period of 
about 4 hr, because the antibody class can be characterized, 
because the results may be read visually, and because very 
small amounts of serum, as little as 10 I.d, are necessary. 
Our finding of antibodies to wheat protein in 12 of 17 GSE 
patients and 5 of 14 DH patients is similar to the results of 
similar studies with other techniques [31,33-35]. The antibodies 
~hich we detected in most patients were from the IgG class; 
IgA antibodies were found only in the sera of 5 GSE patients 
also positive for IgG antibodies. If circulating immune com-
plexes containing wheat protein antigens are involved in the 
pathogenesis of DH, these data would suggest that they may 
contain IgG rather than IgA antibodies. Alternatively, if IgA 
antibody to wheat protein is present in DH patients, it may be 
tightly bound in complexes or deposited in tissue. In previous 
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studies reporting evidence of circulating immune complexes in 
DH patients, IgG and IgM rather than IgA, have been the most 
frequently detected immunoglobulins in the complexes 
[37-39]. We feel that the ELISA for antibodies to wheat protein 
antigens should prove a useful method for evaluating a role of 
these antibodies in a possible immune complex pathogenesis of 
DR 
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